Status:
WITHDRAWN
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
Novartis
Conditions:
Kidney Transplantation
Renal Transplantation
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Patients undergoing living donor renal transplant will be asked to participate to determine whether pre-operative dosing of immunosuppressive medication, and the donor organ receiving an additional do...
Eligibility Criteria
Inclusion
- Must be able to provide written informed consent.
- All recipients of a kidney from a living donor only, either a de novo transplant, or re-transplant
- All patients evaluated and listed with the United Network for Organ Sharing (UNOS) who are eligible to receive a kidney transplant under GUH's standard protocol.
- Patients between 18-80 years of age
Exclusion
- Recipients of multi-organ transplant
- Patients with known allergies of hypersensitivities to any of the drugs used in this protocol
- Recipients of kidneys from a deceased donor
- Recipients who are co-infected with Hepatitis B, Hepatitis C or HIV
- Women who are pregnant
- Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, including women whose career, lifestyle or sexual orientation precludes intercourse with a male partner unless they agree to avoid pregnancy throughout the duration of the trial and for 3 months following the trial.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01149993
Start Date
June 1 2010
End Date
June 1 2012
Last Update
June 9 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.